EUVIMEDEUVIMED entdecken
Open Access

Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis

Brooke M Bullard iD, Sierra J McDonald iD, Thomas D Cardaci, Brandon N VanderVeen iD, Ahmed D Mohammed, Jason L Kubinak, Joseph F Pierre iD, Ioulia Chatzistamou iD, Daping Fan, Lorne J Hofseth, E Angela Murphy iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.05.2024 · 326 (5) · G591-G606

DOI: 10.1152/ajpgi.00004.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.05.2024. Verfasst von Brooke M Bullard und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States. Hauptthemen laut MEDLINE: Intestinal Mucosa, Mice, Inbred C57BL, Gastrointestinal Microbiome, Dextran Sulfate. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current study, we report that panaxynol ameliorates chemically induced murine colitis by improving colonic crypt and mucosal architecture, suppressing colitis-enriched microbes, reducing macrophages, and promoting the differentiation of regulatory T-cells in the colonic lamina propria. This study suggests that this novel natural compound may serve as a safe and effective treatment option for colitis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal MucosaMice, Inbred C57BLGastrointestinal MicrobiomeDextran SulfateColitisAnimalsFemaleMiceFatty AlcoholsDiynesDisease Models, AnimalColonT-Lymphocytes, RegulatoryColitis, Ulcerative

Stichwörter der Autor:innen

American ginsenggoblet cellsmacrophagesmicrobiotaregulatory T-cells

Substanzen

Dextran SulfatefalcarinolFatty AlcoholsDiynes

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States.
  • Department of Nutritional Sciences, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States.
  • Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, South Carolina, United States.
  • Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, United States.

ORCID-Profile: Brooke M Bullard, Sierra J McDonald, Brandon N VanderVeen, Joseph F Pierre, Ioulia Chatzistamou, E Angela Murphy

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)

Zitieren

APA

Bullard, B. M., McDonald, S. J., Cardaci, T. D., VanderVeen, B. N., Mohammed, A. D., Kubinak, J. L., Pierre, J. F., Chatzistamou, I., Fan, D., Hofseth, L. J., & Murphy, E. A. (2024). Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 326(5), G591-G606. https://doi.org/10.1152/ajpgi.00004.2024

Vancouver

Bullard BM, McDonald SJ, Cardaci TD, VanderVeen BN, Mohammed AD, Kubinak JL, et al. Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;326(5):G591-G606. doi:10.1152/ajpgi.00004.2024

BibTeX
@article{Bullard2024,
  author = {Bullard, Brooke M and McDonald, Sierra J and Cardaci, Thomas D and VanderVeen, Brandon N and Mohammed, Ahmed D and Kubinak, Jason L and Pierre, Joseph F and Chatzistamou, Ioulia and Fan, Daping and Hofseth, Lorne J and Murphy, E Angela},
  title = {Panaxynol improves crypt and mucosal architecture, suppresses colitis-enriched microbes, and alters the immune response to mitigate colitis},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2024},
  volume = {326},
  number = {5},
  pages = {G591--G606},
  doi = {10.1152/ajpgi.00004.2024}
}
Kostenlos starten →